OleanderPhoenix Biotechnology executes a Sponsored Research Agreement with Duke University for in vitro research in neurological disorders using PBI-05204 and certain discrete fractions of the whole extract. Posted on February 2009June 2022 by Carlos Torres 06 Feb Phoenix Biotechnology executes a second amendment to its Sponsored Research Agreement with M. D. Anderson Cancer Center. Update on Phase I trial of PBI-05204: ASCO annual meeting poster presentation with discussion.
